Recent data about the role of human papillomavirus (HPV) in oncogenesis of head and neck cancer

Romanian Journal of Morphology and Embryology

Volumn 51, Issue 3, 2010, Pages 437-440

  Badulescu F ^a   Crişan, Anda ^a   Bǎdulescu, Adriana ^b   Schenker, M ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b Department of Surgery   (Poland)

Author keywords

Head and neck cancer; Human papillomavirus; Prognosis; Treatment

Indexed keywords

CLINICAL TRIAL (TOPIC); HEAD AND NECK TUMOR; HUMAN; MALE; PAPILLOMA VIRUS; PATHOLOGY; PHYSIOLOGY; PRECANCER; REVIEW; VIROLOGY;

CLINICAL TRIALS AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS;

EID: 77956988739     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. PEITSARO P, JOHANSSON B., SYRJÄNEN S, Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative realtime PCR technique, J Clin Microbiol, 2002, 40(3):886-891.
2. GILLISON ML, Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity, Semin Oncol, 2004, 31(6):744-754.
3. RINGSTRÖM E, PETERS E, HASEGAWA M, POSNER M, LIU M, KELSEY KT, Human papillomavirus type 16 and squamous cell carcinoma of the head and neck, Clin Cancer Res, 2002, 8(10):3187-3192.
4. LI W, THOMPSON CH, COSSART YE, O'BRIEN CJ, MCNEIL EB, SCOLYER RA, ROSE BR, The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil, Head Neck, 2004, 26(1):1-9.
5. RAMPIAS T, SASAKI C, DIMAIO D, PSYRRI A, Retrovirusmediated delivery of short hairpin RNA targeting human papillomavirus (HPV) 16 E6 and E7 oncogenes and induction of apoptosis in oropharyngeal squamous cell cancer (OSCC) cell line, 2007 ASCO Annual Meeting Proceedings, J Clin Oncol, Part I, 2007, June 20 Suppl, 25(18S):abstract no. 6034.
6. SARAIYA M, KAWAOKA K, Incidence of human papillomavirus (HPV)-related head and neck cancers in the U.S. from 1998-2003: Pre-HPV vaccine licensure, 2007 ASCO Annual Meeting Proceedings, J Clin Oncol, Part I, 2007, June 20 Suppl, 25(18S):abstract no. 6003.
7. CHATURVEDI A, ENGELS E, ANDERSON W, GILLISON M, Incidence trends for human papillomavirus-related (HPV-R) and unrelated (HPV-U) head and neck squamous cell carcinomas (HNSCC) in the United States (US), 2007 ASCO Annual Meeting Proceedings, J Clin Oncol, Part I, 2007, June 20 Suppl, 25(18S):abstract no. 6001.
8. JAGLAL MV, DESAI P, SCHAEFER G, MILLER DM, GHIM S, GOPAL P, HANAN F, JENSON AB, Incidence of human papillomavirus in head and neck squamous cell carcinomas, 2008 ASCO Annual Meeting Proceedings, J Clin Oncol, 2008, May 20 Suppl, 26:abstract no. 17020.
9. HERRERO R, CASTELLSAGUÉ X, PAWLITA M, LISSOWSKA J, KEE F, BALARAM P, RAJKUMAR T, SRIDHAR H, ROSE B, PINTOS J, FERNÁNDEZ L, IDRIS A, SÁNCHEZ MJ, NIETO A, TALAMINI R, TAVANI A, BOSCH FX, REIDEL U, SNIJDERS PJ, MEIJER CJ, VISCIDI R, MUÑOZ N, FRANCESCHI S; IARC MULTICENTER ORAL CANCER STUDY GROUP, Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study, J Natl Cancer Inst, 2003, 95(23):1772-1783.
10. DAHLSTRAND H, HAMMARSTEDT L, LINDQUIST D, YE W, DALIANIS T, MUNCK-WIKLAND E, Human papillomavirus (HPV) as a risk factor for the increase in incidence of tonsillar cancer and its expression of E6 and E7, 2008 ASCO Annual Meeting Proceedings, J Clin Oncol, 2008, May 20 Suppl, 26:abstract no. 6004.
11. RICHARDS KL, COLELLA S, BAGGERLY KA, TSAVACHIDIS S, JAS LC, SCHULLER DE, KRAHE R, Genomic and transcriptomic profiling of Human Papilloma Virus (HPV)-positive head and neck squamous cell carcinomas (HNSCC) identifies a genetically distinct subgroup of head and neck cancers, 2005 ASCO Annual Meeting Proceedings, J Clin Oncol, 2005, Part I of II, June 1 Suppl, 23(16S):abstract no. 5507.
12. FAKHRY C, WESTRA W, LI S, CMELAK A, RIDGE J, PINTO H, FORASTIERE A, GILLISON M, Prognostic significance of human papillomavirus (HPV) tumor status for patients with head and neck squamous cell carcinoma (HNSCC) in a prospective, multi-center phase II clinical trial, 2007 ASCO Annual Meeting Proceedings, J Clin Oncol, 2007, Part I, June 20 Suppl, 25(18S):abstract no. 6000.
13. SISK EA, SOLTYS SG, ZHU S, FISHER SG, CAREY TE, BRADFORD CR, Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma, Head Neck, 2002, 24(9):841-849.
14. HAFKAMP HC, SPEEL EJ, HAESEVOETS A, BOT FJ, DINJENS WN, RAMAEKERS FC, HOPMAN AH, MANNI JJ, A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8, Int J Cancer, 2003, 107(3):394-400.
15. PERRONE F, OGGIONNI M, BIRINDELLI S, SUARDI S, TABANO S, ROMANO R, MOIRAGHI ML, BIMBI G, QUATTRONE P, CANTU G, PIEROTTI MA, LICITRA L, PILOTTI S, TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinaltype adenocarcinoma of the nasal cavity and paranasal sinuses, Int J Cancer, 2003, 105(2):196-203.
16. SMITH EM, RITCHIE JM, SUMMERSGILL KF, KLUSSMANN JP, LEE JH, WANG D, HAUGEN TH, TUREK LP, Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers, Int J Cancer, 2004, 108(5):766-772.
17. SISK EA, BRADFORD CR, JACOB A, YIAN CH, STATON KM, TANG G, HARRIS MO, CAREY TE, LANCASTER WD, GREGOIRE L, Human papillomavirus infection in young versus old patients with squamous cell carcinoma of the head and neck, Head Neck, 2000, 22(7):649-657.
18. LI W, THOMPSON CH, O'BRIEN CJ, MCNEIL EB, SCOLYER RA, COSSART YE, VENESS MJ, WALKER DM, MORGAN GJ, ROSE BR, Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil, Int J Cancer, 2003, 106(4):553-558.
19. LINDEL K, BEER KT, LAISSUE J, GREINER RH, AEBERSOLD DM, Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma, Cancer, 2001, 92(4):805-813.
20. ALSNER J, SØRENSEN SB, OVERGAARD J, TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck, Radiother Oncol, 2001, 59(2):179-185.
21. CABELGUENNE A, BLONS H, DE WAZIERS I, CARNOT F, HOULLIER AM, SOUSSI T, BRASNU D, BEAUNE P, LACCOURREYE O, LAURENT-PUIG P, p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series, J Clin Oncol, 2000, 18(7):1465-1473.
22. TEMAM S, FLAHAULT A, PÉRIÉ S, MONCEAUX G, COULET F, CALLARD P, BERNAUDIN JF, ST GUILY JL, FOURET P, p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck, J Clin Oncol, 2000, 18(2):385-394.
23. DEWEESE TL, WALSH JC, DILLEHAY LE, KESSIS TD, HEDRICK L, CHO KR, NELSON WG, Human papillomavirus E6 and E7 oncoproteins after cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation, Int J Radiat Oncol Biol Phys, 1997, 37(1):145-154.
24. MELLIN H, FRIESLAND S, LEWENSOHN R, DALIANIS T, MUNCKWIKLAND E, Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival, Int J Cancer, 2000, 89(3):300-304.
25. BOSCH FX, ROHAN T, SCHNEIDER A, FRAZER I, PFISTER H, CASTELLSAGUÉ X, DE SANJOSÉ S, MORENO V, PUIGTINTORE LM, SMITH PG, MUÑOZ N, ZUR HAUSEN H, Papillomavirus research update: highlights of the Barcelona HPV 2000 International Papillomavirus Conference, J Clin Pathol, 2001, 54(3):163-175.